Natalie A Prow 9th Australasian Virology Society Meeting 2017

Abstracts this author is presenting:

• A new replication-defective, vaccinia-derived, CHO-manufactured, vaccine vector system (SCV) is effective in preclinical studies. — Recent Advances in Antiviral Therapeutics and Vaccines